Process for preparing nicotinamide

MYPI1996004522A0Inactive Publication Date: 1997-05-01LONZA AG
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MYPI1996004522
Authority / Receiving Office
MY · MY
Patent Type
Applications
Current Assignee / Owner
Priority Date
1995-11-01
Filing Date
1996-10-30
Publication Date
1997-05-01
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

Existing processes for preparing nicotinamide, such as nitric acid oxidation and ammonoxidation of alkylpyridines, are either too complex for technology transfer to resource-limited areas or fall short in catalyst performance metrics like space velocity and operating life, making them unsuitable for industrial scalability.

Method used

A process involving the catalytic conversion of 2-methyl-1,5-diaminopentane to 3-picoline, followed by ammonoxidation to 3-cyanopyridine, and subsequent microbiological conversion to nicotinamide, aiming to simplify the technology and enhance catalyst performance.

Benefits of technology

This process achieves a more accessible and economically viable method for nicotinamide production, improving catalyst efficiency and selectivity, and is easier to master, thus overcoming the limitations of previous methods.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

A NEW PROCESS IS DESCRIBED FOR PREPARING NICOTINAMIDE, WHEREIN IN THE FIRST STAGE 2-METHYL-1,5-DIAMINOPENTANE IS CATALYTICALLY CONVERTED INTO 3-PICOLINE, THE 3-PICOLINE IS CONVERTED VIA AN AMMONOXIDATION INTO 3-CYANOPYRIDINE AND FINALLY THE 3-CYANOPYRIDINE IS CONVERTED MICROBIOLOGICALLY INTO THE END PRODUCT.
Need to check novelty before this filing date? Find Prior Art

Description

A new process is described for preparing nicotinamide, wherein in the first stage 2-methyl-1,5diaminopentane is catalytically converted into 3picoline, the 3-picoline is converted via an ammonoxidation into 3-cyanopyridine and finally the 3-cyanopyridine is converted microbiologically into the end product.Process for preparing nicotinamideThe invention relates to a new process for preparing nicotinamide .Numerous processes are known for the preparation 5 of nicotinamide, one of the B-group vitamins essential to man and beast. Essentially only two processes have achieved industrial importance, namely the nitric acid oxidation of alkylpyridines or the ammonoxidation of alkylpyridines (cf. Ullmann's Encyklopadie der technis10 chen Chemie, 4th edition, Vol. 23, p. 708 ff. or Vol. 19, p. 602 ff.). Although the nitric acid oxidation, specifically of 2-methyl-5-ethylpyridine, is a very selective process, it incorporates a risk potential for the minimization of which highly qualified personnel, optimum infrastructure and a high standard of know-how are indispensable prerequisites. The said process is therefore unsuitable for technology transfer, for example to places where the prerequisites mentioned can only be realised in part.The ammonoxidation, specifically of 3-picoline, has not hitherto come close to the industrial importance of the nitric acid oxidation, although numerous publications describe quantitative conversions with yields of over 90% (cf. Ullmann's Encyklopadie der technischenChemie, 4 th edition, Vol. 19, p. 602 ff.) . Essential prerequisites for an industrially usable catalyst are not only its degree of conversion and its selectivity, but likewise the achievable space velocity over the catalyst (amount of starting material / catalyst volume / time = kg 1-¼-1) and its operating life. Particularly in respect of the last two criteria, the known ammonoxidation catalysts from the prior art are not satisfactory.It is therefore an object of the invention to develop an industrially usable process which, on the one hand, is based on a technology which is relatively simple to master and, on the other hand, meets all criteria and requirements of an economical process.This object is achieved by a process according to

Claims

Claim 1. According to the invention, in the first stage a) 2-methyl-1,5-diaminopentane in the gas phase at 300°400°C and at 0-10 bar gauge pressure is converted into 3-methylpiperidine by passing it over a catalyst containing as active component at least one oxide of Al and / or Si, having at the surface a ratio of acid centres to basic centres of more than 2 and having a specific surface area of more than 40 m2 / g, and immediately afterwards the product is passed at 220°-400°C over a dehydrogenation catalyst and is converted into 3-picoline, then in the second stage b) 3-picoline is, in the presence of ammonia and an oxygen-containing gas, passed at 280°-400°C over an ammonoxidation catalyst comprising the oxides of vanadium, titanium, zirconium and molybdenum in a molar ratio of V2O5 to TiO2 to ZrO2 of from 1:1:2 to 1:12:25 and having an Mo03 content, based on V2O5, from 0.54% by weight to 2.6% by weight, and finally in the third stage c) the resulting 3-cyanopyridine is converted by means of microorganisms of the genus Rhodococcus into the end product. The first process stage, viz. the preparation of 3-picoline from 2-methyl-1,5-diaminopentane, is compr hensively described in the PCT application WO 94 / 22824. The 3-picoline obtained can, without intermediate purification, be fed directly to the ammonoxidation stage. However, it is preferably subjected to, for example, an intermediate purification by distillation, which has a positive effect on the catalyst life in the next stage. The ammonoxidation in the second stage is subject-matter of the PCT application PCT / EP 95 / 01945. As ammonoxidation catalyst, preference is given to using a catalyst composition comprising the oxid s of vanadium, titanium, zirconium and molybdenum in a molar ratio of V2O5 to TiO2 to ZrO2 of from 1:3:4 to 1:8:16 and having an Mo03 content, based on V2O5, of from 0.54% byweight to 1.20% by weight. The preparation of the catalyst is comprehensively described in the abovementioned PCT application PCT / EP 95 / 01945. As oxygen-containing gas, preference is given to using air since air has the advantage that the oxygen is already diluted with inert gases. However, the partial pressure of oxygen can be further regulated by mixing in inert gas such as nitrogen or oxygen-free process gases obtained by recycling. The reactants 3-picoline, ammonia and oxygencontaining gas (calculated as O2) are advantageously passed in gas form and in a molar ratio of from 1:1:1.5 to 1:8.5:60 at 280°-400°C, preferably 310°-380°C, over the catalyst. The preferred molar composition of the feed gas is 3-picoline, ammonia and oxygen-containing gas (calculated as 02) in a ratio of from 1:1:1.5 to 1:4:

25. Water can have a favourable influence on the activity of the catalyst and is advantageously passed over the catalyst in a molar ratio to 3-picoline of between 0 and 5, preferably about 1.

5. In this second stage, yields of 3-cyanopyridine of up to 99% are achieved at a space velocity over the catalyst of from 50 to 150 gl^h'1 of 3-picoline. The catalyst life is likewise extraordinarily high at at least one year. In comparison with the prior art, the present ammonoxidation process, as constituent of the process of the invention, made it possible to develop a process which satisfies all criteria of an industrial reaction. The resulting 3-cyanopyridine can be fed to the biohydrolysis in the form of an aqueous solution, either directly or after a work-up step, e.g. a crystallization, extraction or distillation. A preferred work-up comprises countercurrent extraction of the 3-cyanopyridine with, for example, toluene and subsequent vacuum distillation. The solvent used, e.g. toluene, can be completely recycled. Ί The biohydrolysis of 3-cyanopyridine as substrate to give nicotinamide is advantageously carried out using microorganisms of the species Rhodococcus rhodochrous, 5 Rhodococcus sp. 3-6 or Rhodococcus equi, preferably using microorganisms of the species Rhodococcus sp. s 6 (FERM BP-687), Rhodococcus rhodochrous Jl (FERM BP1478) or using microorganisms of the species Rhodococcus equi TG328 (FERM BP-3791). In particular, the reaction is 10 carried out by means of microorganisms of the species Rhodococcus rhodochrous (FERM BP-1478). The microorganisms of the species Rhodococcus sp. s - 6, Rhodococcus rhodochrous Jl and Rhodococcus equi TG328 are microorganisms described in the literature. Rhodococcus 15 rhodochrous Jl (FERM BP-1478) is comprehensively described in EP-B 307 92 6, Rhodococcus sp. S - 6 (FERM BP687)'in EP-A 0 188 316 and Rhodococcus equi TG328 (FERM BP-3791) in US-A 5 258 305. Likewise suitable for the process are the func20 tionally equivalent variants and mutants of these microorganisms. For the purposes of the present invention, functionally equivalent variants and mutants are microorganisms which have essentially the same properties and functions as the original microorganisms. Such 25 variants and mutants can arise by chance, for example by means of UV irradiation. The microorganisms are usually cultured (grown) and the effective enzymes induced prior to the actual biotransformation as described in EP-B 307 926 . The 30 biotransformation is preferably carried out using, as is customary in the art, immobilized microorganism cells. The biotransformation is advantageously carried out in a pH range from 6 to 10, preferably in a pH range from6.5to8.5 The pH is here advantageously set using a 3 ' suitable phosphate buffer. The biotransformation can be carried out at a temperature of from 5 to 50°C, preferably from 15 to 30°C . Preferably, the biohydrolysis of the 3-cyano5 pyridine, which is advantageously present in aqueous solution in a concentration of from 5 to 30% by weight, is carried out in a reactor cascade comprising from 2 to 5 connected stirred reactors which each contain the biocatalyst. Particular preference is given to using cascades comprising 3 or 4 stirred vessels. The 3-cyanopyridine content of the aqueous solution particularly preferably fluctuates between 10 and 20% by weight. After a residence time of from 5 to 30 hours, the nicotinamide can be isolated from the product stream, for example by crystallization. Preferably, the reaction solution is purified over activated carbon or a polystyrene resin (eg. Amberlite) and the nicotinamide is isolated from the aqueous phase in a conventional manner. The conversion in the biohydrolysis is virtually quantitative and gives a nicotinamide having a purity of over’99.5%. Examples : Example la MPDA (methyldiaminopentane) to 3-picoline: A reactor (13 mm 0) was charged with 4 g of a Pd catalyst (1% Pd / Al2O3) and, on top of that, 3 g of H-ZSM5 (54.5% of pentasil (Sx / Al = 18) + 45.5% of binder). (The starting material was always fed into the reactor from the top.) The reaction conditions were: temperature: 305- 320°C, 15 ml / min of N2, pressure: 5 bar. In a temperature range of 305-320°C and at an MHSV (mass hourly space velocity over the catalyst) of 0.6 g / (g*h), yields of up to 97% of 3-picoline were achieved, with the only further product found being 2.9% of MPI (methylpiperidine) . Thus, complete conversion of the MPDA to desired products took place. No deactivation of the catalysts was observed over a period of 10 days. It is also possible to use H2 as carrier gas in place of N2. Example lb Preparation of 3-picoline using two separate reactors and commercial MPDA (MPDA to 3-picoline in 2 stages with isolation of MPI): 1st stage: A reactor (13 mm 0) was charged with 3 g of ZSM-5 in the ammonium form (particle size: 0.5 - 1 mm). MPDA was vaporized and, together with a carrier gas stream of 15 ml / min of N2, was passed at a pressure of 5 bar and a temperature of 335°C over the catalyst. The MHSV was 4.2 g of MPDA per gram of catalyst per hour. The MPDA used was a commercial product obtainable from Du Pont de Nemours under the trade name Dytek A. The experiment ran for 280 hours. A deactivation of the catalyst was not observed. The product was condensed and the ammonia formed was able to escape. The yields of MPI were virtually quantitative (>99.5%).2nd stage: A reactor (13 mm 0) was charged with 10 g of a Pd-MgCl2 / Al2O3 dehydrogenation catalyst. The MPI from the first stage was passed in vapour form together with a carrier gas stream of 15 ml / min of N2 at a pressure of 1 bar and a temperature of 280°C over the catalyst. The MHSV was 0.23 g of MPI per gram of catalyst per hour. The experiment ran for 190 hours. A deactivation of the catalyst was not observed. After 190 hours, the following product composition was determined by gas chromatography: 99.3% of 3-picoline, 0.4% of MPI. Example lc Preparation of 3-picoline using two separate reactors and commercial MPDA (MPDA to 3-picoline in 2 stages without isolation of MPI): A reactor (13 mm 0) was charged with 3 g of NH4ZSM-5 (particle size: 0.5 - 1 mm) . MPDA was vaporized and, together with a carrier gas stream of 15 ml / min of N2, passed at a pressure of «.bout 1 bar and a temperature of 320°C over the catalyst. The MHSV was between 1 and 2 g of MPDA per gram of ZSM-5 per hour. The MPDA used was a commercial product obtainable from Du Pont de Nemours under the trade name Dytek A. The product from the cyclization reactor was kept in the gas phase and conveyed directly to a second reactor. This reactor contained 12 g of a dehydrogenation catalyst composed of Pd + MgCl2 on an Al2O3 support (particle size: 0.32 - 1 mm) . The reaction conditions were 280°C and about 1 bar. The condensate from the dehydrogenation reactor contained, after a reaction time of 220 hours, 99.1% of 3-picoline and 0.9% of MPI (by gas chromatography). A deactivation of the two catalysts over the reaction time was not observed. Example Id 2-Methyl-1,5-diaminopentane (MPDA) to 3-picoline continuously in 2 stages: A reactor (13 mm 0) was charged with 3 g of SiO2 / A12O3 granules (Si-HP-87-069 T from Engelhard) having a particle size of 0.315 - 1 mm. MPDA was vaporized and, together with a carrier gas stream of 15 ml / min of H2, passed at a pressure of about 1 bar and a reactor temperature of 320°C over the catalyst and cyclized to form MPI. The MPDA used was a commercial product obtainable from Du Pont de Nemours under the trade name Dytek A. The product from the cyclization reactor was kept in the gas phase and conveyed directly to a second reactor. This reactor contained 3 g of the dehydrogenation catalyst from Example 18 of WO 94 / 22 824 (particle size: 0.321 mm) . The reactor temperature was 280°C, the pressure was 1 bar. During the course of the experiment, the starting material MPDA was converted into MPI and then into a crude product (3-MP crude) consisting of a mixture having the following composition: 74.9% of MPI, 13.9% of MPDA, 5.1% of organic impurities (mainly methylcyclopentanediamines) and 6.1% of water. The results together with the associated MHSVs (MHSV based on Reactor 1) are shown in the following table: Starting material MHSV [1 / h] PIC MPI Runn j ng time [h] Deactiva- tion [PIC % / h] GC % by area Dytek A 2.1 99.7 - 71 0 - π _ 3.15 99.6 0.2 25 0 _ π 4.2 98.6 1.4 48 0 MP I 4.1 95.2 3.8 3 - Π „ 3.52 98.6 0.6 92 0 3-MP crude 4.2 93.9 1.5 170 0.0172 Example 2a Ammonoxidation of 3-picoline to 3-cyanopyridine; 36.4 g of vanadium pentoxide, 48.0 g of titanium dioxide, 197.2 g of zirconium dioxide and 0.42 g of molybdenum trioxide were milled in a ball mill. The molar ratio of V2O5:TiO2:ZrO2 was 1:3:8 and the Mo03 content was 1.15% by weight, based on V2O5. Pellets having dimensions of 5 x 5 mm were formed from the mixture. These were subjected to a heat treatment (100° - 120°C, for 6 hours in a stream of air) . 60 cm3 (82 g) of the catalyst thus pretreated were placed in a tube reactor (stainless steel, internal diameter 20 mm, length 10 00 mm) . At a catalyst bed temperature of 330°C, a mixture of 3picoline, air and ammonia was then passed over the catalyst at a feed rate of (g per 1 of catalyst per hour = gl'1h_1) 84 gl'1h*1 of 3-picoline; 2000 1 of air; 9.92 gl1h_1 of ammonia. The molar composition of the feed gas was 3-picoline:02:NH3 = 1:40:1.

3. Accordingly, 25.5 g of 3-picoline were passed over the catalyst in 10 hours. The conversion was 100%. 26.8 g of 3-cyanopyridine were obtained, corresponding to a yield of 95.0%. Example 2b Ammonoxidation of 3-picoline to 3-cyanopyridine (in a multitube reactor without additional thermal treatment of the catalyst) 11.67 kg of vanadium pentoxide, 2 5.12 kg of titanium oxide as metatitanic acid, 63.22 kg of zirconium oxide and 1124 g of molybdenum trioxide (as ammonium paramolybdate) were milled in a ball mill. The molar ratio of V2O5:TiO2:ZrO2 was 1:4:8 and the Mo03 content was 1.13%, based on V2O5. Pellets having dimensions of 6 x 6 mm were formed from the mixture. These were subjected to a heat treatment (100 - 120°C, for 6 hours in a stream of air). A quantity (72 kg, 53 litres) was placed in a tube reactor (stainless steel, internal diameter 21 mm, length 3000 mm, number of tubes 51) . At a catalyst bed temperature of 340°C, a mixture of 3-picoline, air, recirculated waste gas and ammonia was then passed over the catalyst at a feed rate of (g per 1 of catalyst per hour = gl_1h_1) 3.1 kgh’1 of 3-picoline (60 gl'1h'1), 7.6 kgh-1 of air, 67.0 kgh1 of waste gas, 0.84 kgh1 of ammonia. The molar composition of the feed gas was 3picoline:02 :NH3 - 1:1.9:1.

5. Accordingly, 1860 kg of 3picoline were passed over the catalyst in 600 hours. 1880 kg of 3-cyanopyridine were obtained, corresponding to a yield of 90.4%. Example 2c Ammonoxidation of 3-picoline to 3-cyanopyridine (in a single-tube reactor with additional thermal treatment of the catalyst) A quantity of the catalyst obtained in Example 2b (135 cm3, 160 g) was treated thermally at 620°C for 6 hours in a stream of air. This was subsequently placed in a tube reactor (internal diameter 21 mm, length 1000 mm). At a catalyst bed temperature of 375°C, a mixture of 3-picoline, air, nitrog n and ammonia was passed over the catalyst. The feed rate was 11 gh1 of 3-picoline (corresponds to 81 g of picoline per litre of catalyst per hour) , 30 lh'1 of air, 285 lh1 of nitrogen, 4 gh'1 of ammonia, corresponding to a molar ratio of 3-picoline:O2 : NH3 = 1:2:2.

6. After 24 hours, 264 g of picoline had been passed over the catalyst bed. The conversion was 99%. 5 261 g of 3-cyanopyridine were obtained, viz. a yield of 89%. The productivity of 3-cyanopyridine was 80 gl'1h'1. Example 2d Ammonoxidation of 3-picoline to 3-cyanopyridine (in a single-tube reactor with smaller pellets and higher 10 picoline productivity) Pellets having dimensions between 3-4 mm were formed from the catalyst obtained from Example 2b. A quantity (1 litre, 1.5 kg) was placed in a tube reactor (stainless steel, internal diameter 21 mm, length 15 3000 mm). A mixture of 3-picoline, air, nitrogen and ammonia was passed over the catalyst at a catalyst bed temperature of 353°C. The feed rate was 96 gh'1 of 3picoline (corresponds to 96 g of picoline per litre of catalyst per hour) , 210 lh'1 of air, 1340 lh'1 of 2 0 nitrogen, 60 gh1 of ammonia. Accordingly, 23 0 5 g of 3picoline were passed over the catalyst bed in 24 hours. 2380 g of 3-cyanopyridine were obtained, corresponding to a yield of 90%. The 3-picoline conversion was 97.5%. Oxidative ammonolysis of picoline (3-Pic Example 3a Preparation of NA from 3-cyanopyridine In a cascade comprising a 1.125 1 reactor and two 0.375 1 reactors, a 10% strength solution of 3-cyanopyridine was converted into NA. At a throughput rate of 300 ml / h of starting material solution, cyanopyridine was converted quantitatively into NA; the first reactor contained 45 g of immobilized microorganisms (dry weight) and the two further reactors each contained 7.5 g (dry weight) of immobilized microorganisms. The biocatalyst remained in the respective reactors during the entire experiment. The biocatalyst contained immobilized microorganisms of the species Rhodococcus rhodochrous Jl. The reaction occurred at a temperature of 25 ± 1°C and a pH of from 8 to 8.

5. The pH was set using phosphoric acid and sodium hydroxide solution. In this experiment, the reaction of cyanopyridine proceeded for 2400 hours, without the product stream containing more than 0.05% of cyanopyridine, which corresponds to a conversion of >99.5%. The activity of the catalyst was exhausted after this time. Product solution containing from 14 to 15% of NA was filtered through a 0.2 pn sterilizing filter. The clear product solution obtained was subsequently evaporated to dryness. The product obtained contained >99.7% of NA (titration) and corresponded to pharmaceutical quality. Example 3b Preparation of NA from 3-cyanopyridine In a cascade comprising a 150 1 reactor and two 45 1 reactors, a 15% strength solution of 3-cyanopyridine was converted into NA. At a throughput rate of 25 1 / h of starting material solution, cyanopyridine was quantitatively converted into NA; the first reac or contained 6 kg of immobilized microorganisms (dry weight) and the two further reactors each contained 0.9 kg (dry weight) of immobilized microorganisms. The biocatalyst remained in the respective r actors during the entire experiment. The biocatalyst contained immobilized microorganisms of the species Rhodococcus rhodochrous Jl. The reaction occurred at a temperature of 24 ± 2 °C and a pH of from 7 to 8.

5. The pH was set using phosphoric acid and sodium hydroxide solution, with potassium dihydrogen phosphate also being used for buffering (1-3 mg / 1). In this experiment, the reaction of cyanopyridine proceeded for 1800 hours, without the product stream containing more than 0.1% of cyanopyridine, which corresponds to a conversion of >99.0%. The activity of the catalyst was exhausted after this time. Product solution containing from 18 to 20% of NA was subsequently purified continuously in fixed-b d adsorbers (each having a volume of 15.7 1), with from 0.5 to 4% of activated carbon (based on amount of product) and from 0.5 to 2% of Amberlite XAD2 being used. Additionally purified NA solution was subsequently filtered continuouly. Use was made of a threestage filtration system in which the product solution was first fed to a GAF filter (10 - 30 μια. pore size) , subsequently to a sterilizing filter (pore size 0.2 / im) and finally to an ultrafiltration (pore size from 10000 to 30000 Dalton). The filtered product solution was concentrated in a falling-film evaporator to from 60 to 80% of NA. Water removed from the product could be recirculated to the biohydrolysis. The product was isolated in a spray dryer having an integrated fluidized bed (fluidized spray dryer). The product obtained contained >99.7% of NA (titration) and corresponded to pharmaceutical quality. Claims:

1. Process for preparing nicotinamide, characterized in that in the first stage a) 2-methyl-1,5-diaminopentane in the gas phase at 300°400°C and at 0-10 bar gauge pressure is converted into 3-methylpiperidine by passing it over a catalyst containing as active component at least one oxide of Al and / or Si, having at the surface a ratio of acid centres to basic centres of more than 2 and having a specific surface area of more than 40 m2 / g, and immediately afterwards the 3-methylpiperidine is passed at 220°-400°C over a dehydrogenation catalyst and is converted into 3-picoline, then in the second stage b) the 3-picoline is, in the presence of ammonia and an oxygen-containing gas, passed at 280°-400 °C over an ammonoxidation catalyst comprising the oxides of vanadium, titanium, zirconium and molybdenum in a molar ratio of V2O5 to TiO2 to ZrO2 of from 1:1:2 to 1:12:25 and having an Mo03 content, based on V2O5, of from 0.54% by weight to 2.6% by weight, and finally in the third stage c) the resulting 3-cyanopyridine is converted by means of microorganisms of the genus Rhodococcus into the end product.

2. Process according to Claim 1, characterized in that the dehydrogenation catalyst used in the first stage is a noble metal catalyst on a support.

3. Process according to Claim 1 or 2, characterized in that the ammonoxidation catalyst used is a catalyst composition comprising the oxides of vanadium, titanium, zirconium and molybdenum in a molar ratio of V2O5 to TiO2 to ZrO2 of from 1:3:4 to 1:8:16 and having an Mo03 content, based on V2O5, of from 0.54% by weight to 1.2 0% by weight.

4. Process according to at least one of Claims 1 to 3, characterized in that in the second stage 3-picoline, ammonia and the oxygen-containing gas (calculated as 02) are passed in a molar ratio of from 1:1:1.5 to 1:8.5:60 at 310° - 380°C over the catalyst.

5. Process according to Claim 4, characterized in that 3-picoline, ammonia and the oxygen-containing gas (calculated as O2) are passed in a molar ratio of from 1:1:10 to 1:4:60 at from 310° to 380°C over the catalyst.

6. Process according to at least one of Claims 1 to 5, characterized in that the microbiological reaction in the third stage is carried out using microorganisms of the species Rhodococcus rhodochrous or using the functionally equivalent variants and mutants thereof.

7. Process according to Claim 6, characterized in that immobilized microorganisms of the species Rhodococcus rhodochrous are used.

8. Process according to at least one of Claims 1 to 7, characterized in that the microbiological reaction in the third stage is carried out at a pH of from 6 to 10 and a temperature of from 5 to 5 0°C.

9. Process according to at least one of Claims 1 to 8, characterized in that the microbiological reaction in the third stage is carried out in a reactor cascade comprising from 2 to 5 connected stirred reactors.

10. Process for preparing nicotinamide, characterized in that 3-picoline is, in the presence of ammonia and an oxygen-containing gas, passed at 280°-400°C over an ammonoxidation catalyst comprising the oxides of vanadium, titanium, zirconium and molybdenum in a molar ratio of V2O5 to TiO2 to ZrO2 of from 1:1:2 to 1:12:25 and having an MoOj content, based on V2O5, of from 0.54% by weight to 2.6% by weight and the resulting 3-cyanopyridine is subsequently converted by means of microorganisms of the genus Rhodococcus into the end product.

11. Process according to Claim 10, characterized in that the ammonoxidation catalyst used is a catalyst composition comprising the oxides of vanadium, titanium, zirconium . ad molybdenum in a molar ratio of V2O5 to TiO2 to ZrO2 of from 1:3:4 to 1:8:16 and having an Mo03 content, based on V2O5, of from 0.54% by weight to 1.20% by weight.

12. Process according to Claim 10 or 11, character16 ized in that 3-picoline, ammonia and the oxygen-containing gas (calculated as O2) are passed in a molar ratio of from 1:1:1.5 to 1:8.5:60 at 310° - 380°C over the catalyst.

13. Process according to Claim 12, characterized in that 3-picoline, ammonia and the oxygen-containing gas (calculated as O2) are passed in a molar ratio of from 1:1:10 to 1:4:60 over the catalyst.

14. Process according to at least one of Claims 10 to 13, characterized in that the microbiological reaction is carried out using microorganisms of the species Rhodococcus rhodochrous or using the functionally equivalent variants and mutants thereof.

15. Process according to Claim 14, characterized in that immobilized microorganisms of the species Rhodococcus rhodochrous are used.

16. Process according to at least one of Claims 10 to 15, characterized in that the microbiological reaction is carried out at a pH of from 6 to 10 and a temperature of from 5 to 50°C.

17. Process according to at least one of Claims 10 to 16, characterized in that the microbiological reaction is carried out in a reactor cascade comprising from 2 to 5 connected stirred reactors.